X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (68921) 68921
Newsletter (1303) 1303
Newspaper Article (301) 301
Book Chapter (260) 260
Magazine Article (191) 191
Dissertation (93) 93
Publication (75) 75
Conference Proceeding (36) 36
Government Document (21) 21
Book / eBook (16) 16
Book Review (10) 10
Transcript (4) 4
Web Resource (4) 4
Paper (3) 3
Reference (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (45837) 45837
male (21856) 21856
female (21258) 21258
animals (17758) 17758
middle aged (14184) 14184
aged (11748) 11748
plasminogen-activator (10250) 10250
adult (9953) 9953
tissue plasminogen activator (8593) 8593
peripheral vascular disease (8551) 8551
tissue plasminogen activator - therapeutic use (7610) 7610
thrombolytic therapy (7428) 7428
stroke (7410) 7410
fibrinolysis (6687) 6687
hematology (6671) 6671
mice (6365) 6365
thrombolysis (6229) 6229
clinical neurology (5868) 5868
treatment outcome (5868) 5868
tissue-plasminogen activator (5845) 5845
fibrinolytic agents - therapeutic use (5695) 5695
biochemistry & molecular biology (5694) 5694
time factors (5262) 5262
expression (5035) 5035
risk factors (4546) 4546
aged, 80 and over (4454) 4454
cardiac & cardiovascular systems (4452) 4452
rats (4291) 4291
tissue plasminogen activator - administration & dosage (4106) 4106
urokinase (4075) 4075
cells, cultured (4032) 4032
plasminogen-activator inhibitor-1 (4021) 4021
stroke - drug therapy (3913) 3913
oncology (3850) 3850
research (3732) 3732
urokinase-type plasminogen activator - metabolism (3703) 3703
neurosciences (3694) 3694
therapy (3583) 3583
cell biology (3437) 3437
surgery (3376) 3376
acute ischemic-stroke (3331) 3331
thrombosis (3179) 3179
analysis (3062) 3062
thrombolytic therapy - methods (3047) 3047
fibrinolytic agents - administration & dosage (3043) 3043
myocardial infarction - drug therapy (2997) 2997
plasminogen activator inhibitor 1 - metabolism (2955) 2955
prognosis (2946) 2946
care and treatment (2869) 2869
plasminogen activator inhibitor 1 - genetics (2825) 2825
tissue-plasminogen-activator (2754) 2754
urokinase-type plasminogen activator - therapeutic use (2753) 2753
ischemia (2744) 2744
tissue plasminogen activator - metabolism (2712) 2712
retrospective studies (2641) 2641
pharmacology & pharmacy (2563) 2563
plasminogen activator inhibitor 1 - blood (2522) 2522
medicine, general & internal (2520) 2520
prospective studies (2432) 2432
inflammation (2390) 2390
mortality (2336) 2336
acute myocardial-infarction (2326) 2326
proteins (2279) 2279
cancer (2253) 2253
health aspects (2249) 2249
molecular sequence data (2247) 2247
plasminogen activators - metabolism (2201) 2201
disease models, animal (2180) 2180
kinetics (2098) 2098
cells (2087) 2087
acute disease (2080) 2080
endothelial-cells (2077) 2077
cell line (2062) 2062
myocardial-infarction (2054) 2054
brain ischemia - drug therapy (2053) 2053
adolescent (2033) 2033
fibrinolysis - drug effects (1992) 1992
plasma (1981) 1981
tissue plasminogen-activator (1950) 1950
gene expression (1940) 1940
dose-response relationship, drug (1936) 1936
risk (1935) 1935
tissue plasminogen activator - adverse effects (1933) 1933
alteplase (1928) 1928
plasminogen activator (1922) 1922
medicine, research & experimental (1896) 1896
receptors, urokinase plasminogen activator (1882) 1882
receptor (1881) 1881
amino acid sequence (1875) 1875
pai-1 (1853) 1853
metastasis (1847) 1847
plasminogen activators (1832) 1832
urokinase-type plasminogen activator - genetics (1832) 1832
trial (1803) 1803
disease (1800) 1800
tissue plasminogen activator - blood (1796) 1796
neurology (1787) 1787
urokinase-type plasminogen activator - administration & dosage (1776) 1776
gene-expression (1774) 1774
endocrinology & metabolism (1767) 1767
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (67267) 67267
Japanese (1468) 1468
German (1121) 1121
Chinese (688) 688
French (649) 649
Russian (494) 494
Spanish (408) 408
Polish (216) 216
Italian (183) 183
Portuguese (119) 119
Korean (88) 88
Czech (62) 62
Danish (39) 39
Turkish (39) 39
Dutch (35) 35
Hungarian (32) 32
Ukrainian (27) 27
Norwegian (22) 22
Swedish (17) 17
Slovak (14) 14
Persian (13) 13
Serbian (12) 12
Finnish (11) 11
Bulgarian (10) 10
Croatian (9) 9
Hebrew (8) 8
Romanian (7) 7
Icelandic (3) 3
Bosnian (1) 1
Breton (1) 1
Catalan (1) 1
Chamorro (1) 1
Indonesian (1) 1
Slovenian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Brain (London, England : 1878), ISSN 0006-8950, 2012, Volume 135, Issue 11, pp. 3251 - 3264
The neurovascular unit provides a dynamic interface between the circulation and central nervous system. Disruption of neurovascular integrity occurs in... 
traumatic brain injury | matrix metalloproteinase-3 | plasminogen activator inhibitor-1 | tissue plasminogen activator | neurovascular unit | MULTIPLE-SCLEROSIS LESIONS | RECEPTOR-RELATED PROTEIN | TPA | FOCAL CEREBRAL-ISCHEMIA | BARRIER BREAKDOWN | NEUROSCIENCES | CLINICAL NEUROLOGY | STROKE | MATRIX METALLOPROTEINASES | CENTRAL-NERVOUS-SYSTEM | EXPRESSION | BLOOD | Capillary Permeability - physiology | Tissue Plasminogen Activator - metabolism | Brain Injuries - drug therapy | Humans | Middle Aged | Injections, Intraventricular | Capillary Permeability - drug effects | Male | Brain Injuries - metabolism | Brain Injuries - physiopathology | Plasminogen Activator Inhibitor 1 - physiology | Matrix Metalloproteinase Inhibitors - therapeutic use | Brain - metabolism | Dose-Response Relationship, Drug | Brain - blood supply | Tissue Plasminogen Activator - antagonists & inhibitors | Plasminogen Activator Inhibitor 1 - metabolism | Aged, 80 and over | Recovery of Function - physiology | Adult | Disease Models, Animal | Albumins - metabolism | Mice, Inbred C57BL | Plasminogen Activator Inhibitor 1 - administration & dosage | Tissue Plasminogen Activator - administration & dosage | Tissue Plasminogen Activator - physiology | Animals | Brain Injuries - cerebrospinal fluid | Aged | Mice | Matrix Metalloproteinases - metabolism | Stroke | Central nervous system | Membrane permeability | Albumin | Homeostasis | Cerebrospinal fluid | Matrix metalloproteinase | Permeability | Trauma | Plasmin | t-Plasminogen activator | lipoprotein receptors | neuroserpin | plasminogen | Proteolysis | Plasma membranes | Chromium | Serine proteinase | Brain injury | Original
Journal Article
Biochemical journal, ISSN 0264-6021, 12/2007, Volume 408, Issue 2, pp. 203 - 210
PAI-I and PAI-2 (plasminogen-activator inhibitor types I and 2) are inhibitors of cell surface upA (urokinase plasminogen activator). However, tumour... 
Serpin (serine protease inhibitor) | Plasminogen-activator inhibitor type 2 (PAI-2) | Urokinase plasminogen activator (uPA) | Very-low-density lipoprotein receptor (VLDLr) | Plasminogen-activator inhibitor type 1 (PAI-1) | SYSTEM | very-low-density lipoprotein receptor (VLDLr) | PROTEIN | LDL RECEPTOR | BIOCHEMISTRY & MOLECULAR BIOLOGY | PLASMINOGEN-ACTIVATOR INHIBITOR-1 | plasminogen-activator inhibitor type 1 (PAI-1) | serpin (serine protease inhibitor) | urokinase plasminogen activator (uPA) | COMPLEX-FORMATION | RAP COMPLEX | plasminogen-activator inhibitor type 2 (PAI-2) | DENSITY-LIPOPROTEIN-RECEPTOR | UROKINASE RECEPTOR | BINDING-SITE | LIGAND | Humans | Receptors, Cell Surface - metabolism | Receptors, LDL - metabolism | Plasminogen Activator Inhibitor 2 - physiology | Plasminogen Activator Inhibitor 1 - physiology | Breast Neoplasms - metabolism | Receptors, Urokinase Plasminogen Activator | Breast Neoplasms - chemistry | Plasminogen Activator Inhibitor 1 - chemistry | Plasminogen Activator Inhibitor 1 - metabolism | Urokinase-Type Plasminogen Activator - metabolism | Breast Neoplasms - pathology | Plasminogen Activator Inhibitor 2 - metabolism | Protein Structure, Secondary - physiology | Signal Transduction - physiology | Urokinase-Type Plasminogen Activator - chemistry | Tumor Cells, Cultured | Plasminogen Activator Inhibitor 2 - chemistry | Protein Binding - physiology | Protein Structure, Tertiary - physiology | uPA, urokinase plasminogen activator | LDLR, low-density lipoprotein receptor | serpin, serine protease inhibitor | uPAR, urokinase plasminogen activator receptor | VLDLr, very-low-density lipoprotein receptor | PAI, plasminogen-activator inhibitor | RAP, receptor-associated protein | RCL, reactive centre loop | ERK, extracellular-signal-regulated kinase | plasminogen-activator inhibitor type 1 (PAI-1) | LRP, low-density lipoprotein receptor-related protein | SPR, surface plasmon resonance | plasminogen-activator inhibitor type 2 (PAI-2)
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 372, Issue 24, pp. 2285 - 2295
Journal Article
Biochemistry (Easton), ISSN 0006-2960, 03/2017, Volume 56, Issue 12, pp. 1768 - 1784
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 366, Issue 12, pp. 1099 - 1107
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 368, Issue 10, pp. 893 - 903
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 368, Issue 10, pp. 904 - 913
Journal Article